The alteration of RhoA geranylgeranylation and Ras farnesylation breaks the integrity of the blood–testis barrier and results in hypospermatogenesis
The alteration of RhoA geranylgeranylation and Ras farnesylation breaks the integrity of the blood–testis barrier and results in hypospermatogenesis
复制标题
RhoA 香叶基香叶基化和 Ras 法呢基化的改变破坏了血睾屏障的完整性,导致精子生成不足
DOI:
10.1038/s41419-019-1688-9
复制
发表时间:
2019
影响因子:
9
通讯作者:
Chaojun Li
中科院分区:
文献类型:
--
作者:
Ruilou Zhu;Jiangnan Wang;Tianxiang Feng;Xuechun Hu;Chen Jiang;Xiuxing Wang;Kang Li;Yongjuan Sang;Yue Hua;Haixiang Sun;Bing Yao;Chaojun Li
Non-obstructive azoospermia (NOA) severely affects male infertility, however, the deep mechanisms of this disease are rarely interpreted. In this study, we find that undifferentiated spermatogonial stem cells (SSCs) still exist in the basal compartment of the seminiferous tubules and the blood–testis barrier (BTB) formed by the interaction of neighbor Sertoli cells (SCs) is incomplete in NOA patients with spermatogenic maturation arrest. The adhesions between SCs and germ cells (GCs) are also broken in NOA patients. Meanwhile, the expression level of geranylgeranyl diphosphate synthase (Ggpps), a key enzyme in mevalonate metabolic pathway, is lower in NOA patients than that in obstructive azoospermia (OA) patients. AfterGgppsdeletion specifically in SCs, the mice are infertile and the phenotype of the SC-Ggpps−/−mice is similar to the NOA patients, where the BTB and the SC–GC adhesions are severely destroyed. Although SSCs are still found in the basal compartment of the seminiferous tubules, fewer mature spermatocyte and spermatid are found in SC-Ggpps−/−mice. Further examination suggests that the defect is mediated by the aberrant protein isoprenylation of RhoA and Ras family afterGgppsdeletion. The exciting finding is that when the knockout mice are injected with berberine, the abnormal cell adhesions are ameliorated and spermatogenesis is partially restored. Our data suggest that the reconstruction of disrupted BTB is an effective treatment strategy for NOA patients with spermatogenic maturation arrest and hypospermatogenesis.